Propionibacterium skull osteomyelitis treated with daptomycin

Clinical Neurology and Neurosurgery

Volumn 111, Issue 7, 2009, Pages 610-612

  Ghosh, Mayurika ^a   Talwani, Rohit ^a   Gilliam, Bruce L ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Daptomycin; Osteomyelitis; Propionibacterium

Indexed keywords

CEFEPIME; CIPROFLOXACIN; DAPTOMYCIN; METRONIDAZOLE; VANCOMYCIN;

ADULT; ARTICLE; BACTERIUM CULTURE; BONE GRAFT; CASE REPORT; CLINICAL FEATURE; DRUG EFFICACY; GRAFT INFECTION; HUMAN; MALE; OSTEOMYELITIS; POSTOPERATIVE INFECTION; PROPIONIBACTERIUM ACNES; SKULL; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; DAPTOMYCIN; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; MENINGIOMA; NEUROSURGICAL PROCEDURES; OSTEOMYELITIS; PROPIONIBACTERIUM ACNES; SKULL; SPHENOID SINUS; SURGICAL FLAPS; SURGICAL WOUND INFECTION; YOUNG ADULT;

EID: 67650450844     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2009.04.003     Document Type: Article

References (24)

1. Brook I., and Frazier E. Infections caused by Propionibacterium acnes species. Rev Infect Dis 13 5 (1991) 819-822
2. Lalani T., Person A.K., Hedayati S.S., Moore L., Murdoch D.R., Hoen B., et al. Propionibacterium endocarditis: a case series from the International Collaboration on Endocarditis Merged Database and Prospective Cohort Study. Scand J Infect Dis 39 10 (2007) 840-848
3. Zedtwitz-Liebenstein K., Gabriel H., and Graninger W. Pacemaker endocarditis due to Propionibacterium acnes. Infection 31 3 (2003) 184-185
4. Noble R.C., and Overman S.B. Propionibacterium acnes osteomyelitis: case report and review of the literature. J Clin Microbiol 25 2 (1987) 251-254
5. Nisbet M., Briggs S., Ellis-Pegler R., Thomas M., and Holland D. Propionibacterium acnes: an under-appreciated cause of post-neurosurgical infection. J Antimicrob Chemother 60 5 (2007) 1097-1103
6. Beeler B., Crowder J., Smith J., and White A. Propionibacterium acnes: pathogen in central nervous system shunt infection. Report of three cases including immune complex glomerulonephritis. Am J Med 61 6 (1976) 935-938
7. Skinner P., Taylor A., and Coakham H. Propionibacteria as a cause of shunt and postneurosurgical infections. J Clin Path 31 11 (1978) 1085-1089
8. Barazi S.A., Gnanalingham K.K., Chopra I., and van Dellen J.R. Delayed postoperative intracerebral abscess caused by Proprionibacterium acnes: case report and review of the literature. Br J Neurosurg 17 4 (2003) 336-339
9. Viraraghavan R., Jantausch B., and Campos J. Late-onset central nervous system shunt infections with Propionibacterium acnes: diagnosis and management. Clin Pediatr (Phila) 43 4 (2004) 393-397
10. Kelly M.E., Fourney D.R., Guzman R., Sadanand V., Griebel R.W., and Sanche S.E. Propionibacterium acnes infections after cranial neurosurgery. Can J Neurol Sci 33 3 (2006) 292-295
11. Bayston R., Ashraf W., Barker-Davies R., Tucker E., Clement R., Clayton J., et al. Biofilm formation by Propionibacterium acnes on biomaterials in vitro and in vivo: impact on diagnosis and treatment. J Biomed Mater Res A 81 3 (2007) 705-709
12. Lutz M.F., Berthelot P., Fresard A., Cazorla C., Carricajo A., Vautrin A.C., et al. Arthroplastic and osteosynthetic infections due to Propionibacterium acnes. Eur J Clin Microbiol Infect Dis 24 11 (2005) 739-744
13. Launder W.J., and Hungerford D.S. Late infection of total hip arthroplasty with Propionibacterium acnes: a case and review of the literature. Clin Orthop 157 (1981) 170-177
14. Koneman E.W., Allen S.D., Janda W.M., Schreckenberger P., and Winn W. The anaerobic bacteria. Color atlas and textbook of diagnostic microbiology. 5th ed. (1997), Lippincott, Philadelphia p. 709-84
15. Brook I. Isolation of non-sporing anaerobic rods from infections in children. J Med Microbiol 45 1 (1996) 21-26
16. Behra-Miellet J., Calvet L., and Dubreuil L. Activity of linezolid against anaerobic bacteria. Int J Antimicrob Agents 22 1 (2003) 28-34
17. Bayston R., Nuradeen B., Ashraf W., and Freeman B. Antibiotics for the eradication of Propionibacterium acnes biofilms in surgical infection. J Antimicrob Chemother 60 6 (2007) 1298-1301
18. Goldstein E.J.C., and Citron D.M. Comparative activity of ciprofloxacin, ofloxacin, sparfloxacin, Temafloxacin, CI-960, CI-990 and WIN 57273 against anaerobic bacteria. Antimicrob Agents Chemother 36 5 (1992) 1158-1162
19. Pankuch G.A., Jacobs M.R., and Appelbaum P.C. Susceptibilities of 428 gram-positive and -negative anaerobic bacteria to Bay y3118 compared with their susceptibilities to ciprofloxacin, clindamycin, metronidazole, piperacillin, piperacillin-tazobactam, and cefoxitin. Antimicrob Agents Chemother 37 8 (1993) 1649-1654
20. Ramage G., Tunney M.M., Patrick S., Gorman S.P., and Nixon J.R. Formation of Proprionibacterium acnes biofilms on orthopaedic materials and their susceptibility to antimicrobials. Biomaterials 24 19 (2003) 3221-3227
21. Goldstein E.J.C., Citron D.M., Merriam C.V., Warren Y.A., Tyrrell K.L., and Fernandez H.T. In vitro activities of daptomycin, vancomycin, quinupristin-dalfopristin, linezolid, and five other antimicrobials against 307 gram-positive anaerobic and 31 corynebacterium clinical isolates. Antimicrob Agents Chemother 47 1 (2003) 337-341
22. Tyrrell K.L., Citron D.M., Warren Y.A., Fernandez H.T., Merriam C.V., and Goldstein E.J. In vitro activities of daptomycin, vancomycin, and penicillin against Clostridium difficile, C. perfringens, Finegoldia magna, and Propionibacterium acnes. Antimicrob Agents Chemother 50 8 (2006) 2728-2731
23. Roveta S., Marchese A., and Schito G.C. Activity of daptomycin on biofilms produced on a plastic support by Staphylococcus spp. Int J Antimicrob Agents 31 4 (2008) 321-328
24. Lalani T., Boucher H.W., Cosgrove S.E., Fowler V.G., Kanafani Z.A., Vigliani G.A., et al. Outcomes with daptomycin versus standard therapy for osteoarticular infections associated with Staphylococcus aureus bacteraemia. J Antimicrob Chemother 61 1 (2008) 177-182